Smith Stan's Form 4 filing
MAIA Biotechnology, Inc. (MAIA) · filed Mar 22, 2023
- Accession no.
- 0001127602-23-010968
- Filed
- Mar 22, 2023
- Trade date
- Mar 20-21, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $18.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith StanCIK 0001913199 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 20, 2023 | Common Stock | PPurchaseAcquired | +3,006 | $3.28 | +$9,859.68 | 536,334 | Indirect | |
| Mar 21, 2023 | Common Stock | PPurchaseAcquired | +2,736 | $3.17 | +$8,673.12 | 539,070 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.